1,367 filings
6-K
AZN
Astrazeneca plc
11 Apr 24
Result of Agm
1:22pm
6-K
AZN
Astrazeneca plc
11 Apr 24
Astrazeneca Increases 2024 Dividend by 7%
6:55am
6-K
AZN
Astrazeneca plc
8 Apr 24
Enhertu Approved In Us for HER2+ Solid Tumours
6:14am
6-K
AZN
Astrazeneca plc
5 Apr 24
Imfinzi Improved Os & PFS In Limited-stage SCLC
6:22am
6-K
AZN
Astrazeneca plc
2 Apr 24
Total Voting Rights
1:22pm
6-K
ltl3fh
2 Apr 24
Voydeya Approved In Us
8:45am
6-K
1ip zaxwz
2 Apr 24
Fda Accepts Dato-dxd Bla for Breast Cancer
7:54am
6-K
db3ic rs3so46hg1w9
25 Mar 24
Ultomiris Approved In the Us for Nmosd
7:28am
6-K
nd7iev4
19 Mar 24
Current report (foreign)
6:02am
6-K
abhby8
14 Mar 24
Astrazeneca to Acquire Amolyt
7:12am
6-K
5ohi885 ql2q4gdn
12 Mar 24
Director/pdmr Shareholding
7:29am
6-K
dtdjra t8oj8b1
7 Mar 24
Current report (foreign)
6:34am
6-K
hxsoxj3 f5vvogv3x
7 Mar 24
Notice of Agm
6:30am
6-K
w7a0bla7tv1o7hzppw2
6 Mar 24
Director/pdmr Shareholding
10:11am
6-K
hz60sp54axm8a8n 2v7
6 Mar 24
Director/pdmr Shareholding
10:06am
6-K
7hxkgsjzw5el u4k
4 Mar 24
Ema Validates Dato-dxd Maas for NSQ NSCLC and BC
6:33am
6-K
1ylgud39
1 Mar 24
Total Voting Rights
10:39am
6-K
sxjtpzmwr1c
26 Feb 24
Current report (foreign)
4:05pm
6-K
c1gkz
26 Feb 24
Voydeya Recommended for Eu Approval
6:19am
6-K
ady62
22 Feb 24
Astrazeneca Prices a $5BN Bond Offering
9:19am